Details for Patent: 9,089,534
✉ Email this page to a colleague
Summary for Patent: 9,089,534
Title: | Pharmaceutical semi-solid composition of isotretinoin |
Abstract: | An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle. |
Inventor(s): | Vanderbist; Francis (Rhode-Saint-Genese, BE), Servais; Cecile (Mehaigne, BE), Baudier; Philippe (Brussels, BE) |
Assignee: | Galephar Pharmaceutical Research, Inc. (Puerto Rico 00777, unknown) |
Application Number: | 13/713,897 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,089,534 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Formulation; |
Drugs Protected by US Patent 9,089,534
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,089,534
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 270544 | ⤷ Sign Up | |||
Australia | 8943801 | ⤷ Sign Up | |||
Brazil | 102013032172 | ⤷ Sign Up | |||
Canada | 2423170 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |